Skip to Main Content

Author Details

Romel Rosales
Icahn School of Medicine at Mount Sinai
2012
24
13
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36894709Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection.Nat Genet2023
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
36812912Bat pluripotent stem cells reveal unusual entanglement between host and viruses.Cell2023
35332335Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
35652656The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells.J Virol2022
35766385Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.ACS Infect Dis2022
36558898SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules.Pharmaceuticals (Basel)2022
35012962Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.Life Sci Alliance2022
34942634Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
34112877Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.Sci Rep2021
33495306Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science2021
33821262Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.Res Sq2021
34873243Flavivirus infections induce a Golgi stress response in vertebrate and mosquito cells.Sci Rep2021
34663813Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.Nat Commun2021
34326236Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.Science2021
34075384Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.medRxiv2021
33984267Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.Cell Rep2021
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
30463973The Dengue Virus Nonstructural Protein 1 (NS1) Is Secreted from Mosquito Cells in Association with the Intracellular Cholesterol Transporter Chaperone Caveolin Complex.J Virol2019
29269104Dengue virus induced changes in Ca<sup>2+</sup> homeostasis in human hepatic cells that favor the viral replicative cycle.Virus Res2018
29921331Can the intake of antiparasitic secondary metabolites explain the low prevalence of hemoparasites among wild Psittaciformes?Parasit Vectors2018
23111094Trypanosoma evansi kDNA minicircle found in the Venezuelan nectar-feeding bat Leptonycteris curasoae (Glossophaginae), supports the hypothesis of multiple origins of that parasite in South America.Parasitol Int2013
23582233Detection of Theileria equi and Babesia caballi infections in Venezuelan horses using Competitive-Inhibition ELISA and PCR.Vet Parasitol2013
23050478Hemosporidian parasites in forest birds from Venezuela: genetic lineage analyses.Avian Dis2012
  • 1 - 24 of 24

Recommended Authors

Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 19
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 21
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Career Start Year 2011
Number of shared co-authors 12
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 5
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 4
College of Veterinary Medicine, Kansas State University
Career Start Year 2009
Number of shared co-authors 15
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 1
Brigham Young University
Career Start Year 2009
Number of shared co-authors 4
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 6
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 4
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 5
Rutgers University
Career Start Year 2007
Number of shared co-authors 3
Fundacion Instituto Leloir-CONICET
Career Start Year 2006
Number of shared co-authors 1
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 0
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 1
DUKE-NUS Graduate Medical School
Career Start Year 2004
Number of shared co-authors 0
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 6
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 4
University of California davis
Career Start Year 2002
Number of shared co-authors 11
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 9
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 11
University of California San Francisco
Career Start Year 1994
Number of shared co-authors 31
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 0
Boston University
Career Start Year 1991
Number of shared co-authors 6
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 7
University of North Carolina
Career Start Year 1981
Number of shared co-authors 14
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 15
Icahn School of Medicine at Mount Sinai
Co-authored papers 13
University of California San Francisco
Co-authored papers 8
University of California San Francisco
Co-authored papers 7
J. David Gladstone Institutes
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
University College London
Co-authored papers 5
J. David Gladstone Institutes
Co-authored papers 5
University College London
Co-authored papers 5
J. David Gladstone Institutes
Co-authored papers 5
University of California San Francisco
Co-authored papers 5
University College London
Co-authored papers 4
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 4
University of California, San Francisco
Co-authored papers 4
University College London
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
University of California, University of California San Francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Departamento de Toxicologia y Farmacologia Preclinica
Co-authored papers 3
University College London
Co-authored papers 3
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 3
University of Geneva
Co-authored papers 3
University College London
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Massachusetts Institute of Technology
Co-authored papers 3
European Bioinformatics Institute
Co-authored papers 3
University College London
Co-authored papers 3